Regulatory in brief | paracetamol, ranitidine, GSK

26 June 2020 - Deborah Wilkes

Archived

France is establishing national production of paracetamol, the European Medicines Agency (EMA) is set to take another look at ranitidine, and GlaxoSmithKline (GSK) Consumer Healthcare has recalled some children’s medicines.

Click tags below for more information on topics:

EMA COVID-19 Sanofi Consumer Healthcare Taisho

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: